Docetaxel CAS 114977-28-5

Description:

Nomen chemicum: Docetaxel

Synonyma: Taxotus

CAS: 114977-28-5

Intenta: 98.0%~ 102.0%

Aspectus: Crystallinus Powder Alba

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

114977-28-5 - Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica Docetaxel (Taxotere) (CAS: 114977-28-5) cum qualitate alta.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Docetaxel,Please contact: alvin@ruifuchem.com

114977-28-5 - Chemical Properties:

Nomen chemicum Docetaxel
Synonyma Triticum aestivum;Triticum aestivum;Docetaxel Anhydrous;N-Debenzoyl-N-tert-Butoxycarbonyl-10-Deacetyltaxol;RP-56976
Stock Status In Stock, Commercial Productio
CAS Number 114977-28-5
Formulae hypotheticae C43H53NO14
M. Pondus 807.89 g/mol
Liquescens punctum 186.0~192.0℃(dec.)
Density 1.38
Solubilitas Valde solutum in Acetone, Dimethylformamide.Solutum in Ethanol, Dichloromethane, Methanol.Insolubilis in aqua
COA & MSDS Praesto
Origin Shanghai, China
Brand Ruifu Chemical

114977-28-5 - Formularium:

Items Specifications Proventus
Aspectus Crystallina pulveris alba Crystallina pulveris alba
Lepidium sativum IR & HPLC Conforms
Imprimis Rotationes [a]20/D -42.0° ad -45.0° (C=1 in EtOH) -43.1°
Damnum in Siccatio <3.00% 2.05%
Residere in Ignition <0.10% 0.04%
Metalla gravia (Pb) ≤20ppm <20ppm
Arsenicum (As) ≤1.5ppm <1.5ppm
Substantiae cognatae    
Maximum Impuritas <0.50% <0.50%
Totalis immunditias <1.00% <1.00%
Microbial Low Test
TAMC ≤100cfu/g* <100cfu/g
TYMC ≤10cfu/g* <10cfu/g
Bacterial Endotoxins ≤0.3IU/mg <0.3IU/mg
Asssay / Analysis Methodo 98.0%~ 102.0% (De Anhydrous et Solvendo-Free Basis) 100.9%
conclusio Productum probatum est et cum datis specificationibus obsequitur

Sarcina / at /naviportans:

Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono:Continentem arcte clausam et in loco frigido, sicco (2~8℃) reponunt et a cellis bene ventilatis ab substantiis incompossibilibus.A luce et humore protege.Agentibus oxidizing fortis repugnat.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

114977-28-5 - Informationes Salutis:

Periculosam symbola Xi - Irritant
Periculum Codes
R36/37/38 - Irritando ad oculos, systema respiratorium et cutem.
R61 - Sit partus nocumentum
Salus Descriptio
S26 - In contactu cum oculis, statim cum aqua multa ablue et consilium medicinae quaeras.
S36/37 - indumentis tutelae idoneis gere et caestus.
S53 - expositionis vitandae - speciales instructiones ante usum obtinendum.
S45 - In casu casu vel si bene sentis, consilium medicinae statim quaere (titalam quoties fieri potest).
IR IDs 1544
WGK Germania 3
RTECS DA4172750
HS Code 2932999029
Aleam Class 6.1(b)
Stipare Group III
Toxicity LD50 intravenous in cane: 2500ug/kg

114977-28-5 - Applicatio:

Docetaxel (Taxotere) (CAS: 114977-28-5) venditum Taxotere vel Docecad est bene confirmatum medicamentum chemotherativum anti-mitoticum, quod opera divisionis cellae impedit.Docetaxel approbatur a FDA ad curationem cancri metastatici localiter progressi, cancri capitis et colli, cancer gastrici, hormone-refractorii cancer prostatae et cancri non minimi pulmonis.Docetaxel uti potest pro uno agente vel in compositione cum aliis medicamentis chemotherapeuticis prout indicatis secundum speciem et scaenam cancer specificae.Docetaxel membrum pharmaci taxanei est, quod etiam medicamentum chemotherapeuticum paclitaxel includit.Etsi docetaxel bis potentius ac paclitaxel manet (ob effectum in centrosome fusi mitotici docetaxel), duo taxanei observati sunt ad efficaciam comparandam.Plures articuli recentes recentes nullum invenerunt documenta quae diaetam continentem docetaxel maiora utilitates cedere quam quae paclitaxel possidet.Dum efficacia inter duos agentes observata est aequivalens, paclitaxel pauciores effectus latus causare potest.Accedit, quod docetaxel observatum est ad resistentiam cellulosam medicamento propensam per varias machinas varias.
1. Docetaxel chemotherapy mitotica medicinalis (id est, divisionem cellularum impedit).
2. Docetaxel in curatione pectoris, ovarii, et non parvae cellulae pulmonis cancri praecipue adhibetur.
3. Docetaxel FDA approbatam vindicationem curationi aegrorum, qui localiter progressi sunt, vel pectus metastaticum vel cancer pulmonis non minimi, qui anthracyclinam chemotherapyam subiverunt, et progressionem cancri vel relapsi obsistere neglexerunt.Approbatio Europaea doce-taxel usus est in cancro prostatae hormone-refractorio.
4. Docetaxel melior censetur quam antimicrotubula cytotoxica.

Epistulam tuam hic scribe et mitte nobis